BiotechTube
Home/MingSight Pharmaceuticals/Michael Niesman
MN

Michael Niesman

Chief Scientific Officer

MingSight Pharmaceuticals

Therapeutic Areas

OphthalmologyOncology

MingSight Pharmaceuticals Pipeline

DrugIndicationPhase
MS-553Diabetic Macular Edema (DME) / Diabetic Retinopathy (DR)Phase 1b/2

Leadership Team at MingSight Pharmaceuticals

KZ
Kai Zhang
Chief Executive Officer
View full MingSight Pharmaceuticals profile